Glycoscience Research Inc

Glycoscience Research Inc., based in White, SD, focuses on the research and clinical development of GM1 ganglioside, a compound that may offer therapeutic benefits for individuals living with Huntington's, Parkinson's, and Alzheimer's diseases, among other neurological disorders. With a commitment spanning over two decades, the organization actively works to bring GM1 to clinical trials to improve the quality of life for those affected by these debilitating conditions.

The company is driven by a passion for exploring the potential of GM1 ganglioside, collaborating with initiatives like The Shepherd’s Gift GM1 for Huntington's Disease. Glycoscience Research Inc. invites others to join them on their journey toward bringing effective treatments to those in need.

Generated from the website